Postmortem interval estimation: A novel approach utilizing gas chromatography/mass spectrometry-based biochemical profiling

Analytical and Bioanalytical Chemistry

Volumn 408, Issue 12, 2016, Pages 3103-3112

  Kaszynski, Richard H ^a,b   Nishiumi, Shin ^a   Azuma, Takeshi ^a   Yoshida, Masaru ^a   Kondo, Takeshi ^a   Takahashi, Motonori ^a   Asano, Migiwa ^c   Ueno, Yasuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GC MS; Metabolomics; Postmortem interval (PMI); Time of death

Indexed keywords

BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHY; CURVE FITTING; MAMMALS; METABOLITES; MOLECULAR WEIGHT; MUSCLE; SPECTROMETRY;

BIOCHEMICAL PROFILING; GAS CHROMATOGRAPHY/MASS SPECTROMETRY; GC-MS; METABOLOMIC PROFILING; METABOLOMICS; NON-LINEAR LEAST SQUARES; POST MORTEM INTERVALS; TIME OF DEATH;

GAS CHROMATOGRAPHY;

ANIMAL; C57BL MOUSE; MALE; MASS FRAGMENTOGRAPHY; MOUSE; POSTMORTEM CHANGE; PROCEDURES;

ANIMALS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MICE; MICE, INBRED C57BL; POSTMORTEM CHANGES;

EID: 84959355209     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-016-9355-9     Document Type: Article

References (41)

1. Madea B, Henssge C, Honig W, Gerbracht A. References for determining the time of death by potassium in vitreous humor. Forensic Sci Int. 1989;40:231-43.
2. Bocaz-Beneventi G, Tagliaro F, Bortolotti F, Manetto G, Havel J. Capillary zone electrophoresis and artificial neural networks for estimation of the post-mortem interval (PMI) using electrolytes measurements in human vitreous humour. Int J Legal Med. 2002;116:5-11.
3. James RA, Hoadley PA, Sampson B. Determination of postmortem interval by sampling vitreous humour. Am J Forensic Med Pathol. 1997;18:158-62.
4. Henssge C, Althaus L, Bolt J, Freislederer A, Haffner H-T, Henssge CA, et al. Experiences with a compound method for estimating the time since death. I. Rectal temperature nomogram for time since death. Int J Legal Med. 2000;113:303-19.
5. Huang Q, Tan YX, Yin PY, Ye GZ, Gao P, Lu X, et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 2013;73(16):4992-5002.
6. Schmidt TM, Wang ZJ, Keller S, Heinemann A, Acar S, Graessner J, et al. Postmortem 31P magnetic resonance spectroscopy of the skeletal muscle: α-ATP/Pi ratio as a forensic tool? Forensic Sci Int. 2014;242:172-6.
7. Hirakawa K, Koike K, Uekusa K, Nihira M, Yuta K, Ohno Y. Experimental estimation of postmortem interval using multivariate analysis of proton NMR metabolomic data. Legal Med. 2009;11:S282-5.
8. Prahlow J (2010) Forensic pathology for police, death investigators, attorneys, and forensic scientists. In: Press H, editor.
9. Mallach HJ. Zur frage der todeszeitbestimmung. Berl Med. 1964;18:577-82.
10. Kobayashi M, Takatori T, Nakajima M, Sakurada K, Hatanaka K, Ikegaya H, et al. Onset of rigor mortis is earlier in red muscle than in white muscle. Int J Leg Med. 2000;113:240-3.
11. Marshall TK, Hoare FE. The use of the body temperature in estimating the time of death. J Forensic Sci. 1962;7:211-21.
12. Vanezis P, Trujillo O. Evaluation of hypostasis using a colorimeter measuring system and its application to assessment of the post-mortem interval (time of death). Forensic Sci Int. 1996;78:19-28.
13. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2007;26(1):51-78.
14. Lokhov PG, Dashtiev MI, Moshkovskii SA, Archakov AI. Metabolite profiling of blood plasma of patients with prostate cancer. Metabolomics. 2010;6(1):156-63.
15. Duarte IF, Rocha CM, Gil AM. Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis. Expert Rev Mol Diagn. 2013;13(7):737-48.
16. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910-4.
17. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69:4918-25.
18. Yoshida M, Hatano N, Nishiumi S, Irino Y, Izumi Y, et al. Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry. J Gastroenterol. 2012;47:9-20.
19. Nishiumi S, Shinohara M, Ikeda A, Yoshie T, Hatano N, et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics. 2010;6:518-28.
20. Tsugawa H, Bamba T, Shinohara M, et al. Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis. J Biosci Bioeng. 2011;112:292-8.
21. Tsugawa H, Tsujimoto Y, Arita M, et al. GC/MS based metabolomics: development of a data mining system for metabolite identification by using soft independent modeling of class analogy (SIMCA). BMC Bioinformatics. 2001;12:131.
22. Ackermann K, Ballantyne KN, Kayser M. Estimating trace deposition time with circadian biomarkers: a prospective and versatile tool for crime scene reconstruction. Int J Legal Med. 2010;124(5):387-95.
23. Kimura A, Ishida Y, Hayashi T, Nosaka M, Kondo T. Estimating time of death based on the biological clock. Int J Legal Med. 2011;125:385-91.
24. Bojkowski CJ, Aldhous ME, English J, Franey C, Poulton AL, Skene DJ, et al. Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man. Horm Metab Res. 1987;19:437-40.
25. Hack LM, Lockley SW, Arendt J, Skene DJ. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms. 2003;18:420-9.
26. Thompson C, Franey C, Arendt J, Checkley SA. A comparison of melatonin secretion in depressed patients and normal subjects. Br J Psychiatry. 1988;152:260-5.
27. Latil M, Rocheteau P, Châtre L, Sanulli S, Mémet S, Ricchetti M, et al. Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity. Nat Commun. 2012;3:903.
28. Bauer M, Gramlich I, Polzin S, Patzelt D. Quantification of mRNA degradation as possible indicator of postmortem interval - a pilot study. Leg Med. 2003;5(4):220-7.
29. Sabucedo AJ, Furton KG. Estimation of postmortem interval using the protein marker cardiac troponin I. Forensic Sci Int. 2003;134(1):11-6.
30. Thaik-Oo M, Tanaka E, Tsuchiya T, Kominato Y, Honda K, Yamazaki K, et al. Estimation of postmortem interval from hypoxic inducible levels of vascular endothelial growth factor. J Forensic Sci. 2002;47(1):186-9.
31. Boy SC, Bernitz H, Van Heerden WF. Flow cytometric evaluation of postmortem pulp DNA degradation. Am J Forensic Med Pathol. 2003;24(2):123-7.
32. Singh D, Prashad R, Sharma S, Pandeya. Double logarithmic, linear relationship between postmortem vitreous sodium/potassium electrolytes concentration ratio and time since death in subjects of Chandigarh zone of north-west India's IAFM. 2005;27(3):159-164 15.
33. Prasad BK, Choudhary A, Sincha TNA. Study of correlation between vitreous potassium level and postmortem interval. Kathmandu Univ Med J. 2003;1(2):132-4.
34. Amith M, Jawahar K. Vitreous humour biochemical constituents - evaluation of eye differences. Am J Forensic Med Pathol. 2005;26(2):146-9.
35. Green M, Wright JC. Post-mortem interval estimation using body temperature data only. Forensic Sci Int. 1985;28(1):53-62.
36. Nelson E. Estimation of short-term postmortem interval utilizing core body temperature: a new algorithm. Forensic Sci Int. 2000;109:31-8.
37. Bleavins MR, Carini C, Jurima-Romet M, Ramin R. Biomarkers in drug development: a handbook of practice, application and strategy. Hoboken: Wiley-Blackwell; 2010.
38. Sato et al. A preliminary study on postmortem interval estimation of suffocated rats by GC-MS/MS-based plasma metabolic profiling. Anal Bioanal Chem. 2015;407:3659-65.
39. Kaszynski RH, Nishiumi S, Kondo T, Takahashi M, Kuse A, Asano M, Yoshida M, Azuma T, Ueno Y. Estimation of post-mortem interval: a novel approach utilizing serum and muscle metabolomics profiling. Oral presentation at the 97th Congress of the Japanese Society of Legal Medicine, Sapporo, Japan; 2013.
40. Kaszynski RH, Nishiumi S, Kondo T, Takahashi M, Kuse A, Asano M, Yoshida M, Azuma T, Ueno Y. Muscle and serum metabolomics profiling: a novel method for estimating post-mortem interval. Oral presentation at 9th International Symposium on Advances in Legal Medicine, Fukuoka, Japan; 2014.
41. Sampaio-Silva F, Magalhães T, Carvalho F, Dinis-Oliveira RJ, Silvestre R, Kayser M. Profiling of RNA degradation for estimation of post mortem interval. PLoS One. 2013;8(2):e56507.